Latest Commercialization News

D3 Energy has achieved a significant milestone with maiden reserve certification for its South African ER315 permit, alongside a 32% boost in gas flow rates and strategic expansions into Australia and South Africa.

Proteomics International Laboratories has secured $12 million to fast-track its precision diagnostic tests, including the US launch of PromarkerD for diabetic kidney disease, backed by a new AMA billing code. The company also advances its pipeline with new patents and commercial partnerships.

Volt Group Limited (ASX – VPR) has initiated an on-market share buy-back of up to 5% of its issued capital, aligning with its capital management strategy as it advances commercialisation of its innovative zero-emission technologies.

Carnegie Clean Energy has signed a pivotal Memorandum of Understanding with BiMEP to develop a 6MW wave energy array in Spain’s Basque Country, marking a significant step in commercialising its CETO technology.

Viridis Mining and Minerals has been selected by Brazil's BNDES and FINEP to receive significant funding under a US$903 million strategic minerals initiative, accelerating its Colossus rare earths project and downstream operations.

Sovereign Metals’ latest testwork confirms Kasiya graphite’s premium quality amid sweeping US tariffs on Chinese imports, spotlighting its potential as a strategic non-Chinese supply source for battery manufacturers.

Chilwa Minerals reports encouraging metallurgical testwork from its Mposa Deposit, confirming the potential for commercial-grade ilmenite and promising by-products including zircon and rare earth minerals. These findings will shape the upcoming Scoping Study and flowsheet design.

Eagle Mountain Mining reports steady progress on its Arizona copper assets, including ongoing exploration and a strategic board reshuffle, while maintaining a $1.1 million cash position.

Imricor Medical Systems reported significant regulatory and commercial progress in Q2 CY25, including CE mark approvals and expanded clinical trials, while maintaining a strong cash position.

Brazilian Critical Minerals reports exceptional pilot field trial results at its Ema rare earth project, advancing permitting and feasibility studies while attracting strong market interest.

Advanced Health Intelligence Ltd (AHI) reports robust commercial progress and strategic funding moves in Q1 2025 despite ongoing ASX trading suspension and recent NASDAQ delisting. Key partnerships and technology validations position the company for a strong global scale-up.

Lifestyle Communities faces a pivotal VCAT ruling that voids a key deferred management fee clause, prompting an appeal and interim stay that allows fee collection to continue amid legal uncertainty.